CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 316 filers reported holding CUBIST PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.12 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $13,982,000 | +1906.0% | 138,915 | +1221.7% | 0.21% | +1960.0% |
Q3 2014 | $697,000 | -4.7% | 10,510 | +0.4% | 0.01% | -9.1% |
Q2 2014 | $731,000 | -4.3% | 10,470 | +0.2% | 0.01% | -8.3% |
Q1 2014 | $764,000 | +6.7% | 10,444 | +0.5% | 0.01% | +9.1% |
Q4 2013 | $716,000 | +20.1% | 10,394 | +10.8% | 0.01% | +10.0% |
Q3 2013 | $596,000 | – | 9,380 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ICON ADVISERS INC/CO | 98 | $4,000 | 1.41% |
PALISADE CAPITAL MANAGEMENT, LP | 238,765 | $10,040,000 | 0.33% |
Zurcher Kantonalbank (Zurich Cantonalbank) | 40,000 | $1,682,000 | 0.07% |
AMUNDI ASSET MANAGEMENT US, INC. | 247,900 | $10,427,000 | 0.04% |
First Horizon Advisors, Inc. | 420 | $18,000 | 0.01% |
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp | 9,916 | $417,000 | 0.00% |
MUFG Americas Holdings Corp | 2,500 | $105,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 132,756 | $5,583,000 | 0.00% |
AQR Capital Management | 10,974 | $462,000 | 0.00% |
GOLDMAN SACHS GROUP INC | 43,900 | $1,846,000 | 0.00% |